Clinical Trials

/Tag: Clinical Trials

Ignyta Announces Results for Potential New Cancer Treatment

Dr. Alexander Drilon of Memorial Sloan Kettering Cancer Center recently reported at AACR on a potential new cancer treatment, Entrectinib, a receptor tyrosine kinase (RTK) inhibitor developed to target tumors carrying NTRK1, NTRK2, NTRK3, [...]

By |2018-10-30T09:42:39-04:00July 12th, 2016|Clinical Trials, News, Research|

14th NIH Pediatric and Wildtype GIST Clinic Convenes

Sara Rothschild (LRG), Erin MacBean (LRG), Phyllis Gay (GSI) and Becky Besenhaver (GSI) By Rebecca Bensenhaver, GIST Support International Representative The 14th Pediatric and Wildtype GIST Clinic was held at the National [...]

By |2018-10-30T09:42:45-04:00June 23rd, 2016|News, Pediatric GIST|

Update on Blueprint Medicines Clinical Trial for BLU-285

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

By |2018-10-30T09:50:21-04:00May 24th, 2016|Clinical Trials, News, Research|

ASCO Recommends Expanding Clinical Trials to Include More Older Adults

A recent call to action from ASCO (American Society of Clinical Oncology) published in the Journal of Clinical Oncology recommends expanding clinical trials to include more older adults. Given that greater than 60% of cancers in [...]

By |2018-11-05T15:21:56-04:00July 23rd, 2015|Advocacy, Clinical Trials, News|

Recent Posts

Upcoming Events

  1. GDOL Vancouver logo

    GIST Day of Learning – Vancouver

    April 27 @ 9:00 AM - 4:00 PM
  2. GIST DO IT NJ

    May 4 @ 8:00 AM - 11:00 AM